Gut bacteria may help bladder cancer patients avoid surgery
NCT ID NCT07474064
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether adding a probiotic (Clostridium butyricum) to a combination of targeted therapy (Disitamab Vedotin) and immunotherapy (Toripalimab) can help preserve the bladder in people with muscle-invasive bladder cancer who cannot take the chemotherapy drug cisplatin. About 146 participants will receive either the probiotic plus the drug combo or the drug combo alone for one year. The main goal is to see if the probiotic extends the time the bladder remains cancer-free without needing removal.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Probiotic (Clostridium butyricum), Disitamab Vedotin, Toripalimab
- What this could lead to
- If it works, this could offer a way to treat muscle-invasive bladder cancer without removing the bladder, potentially improving quality of life for patients who cannot take standard chemotherapy.
- What could go wrong
- This is a phase 2 trial with only 146 participants, so results are preliminary. The combination therapy may cause side effects, and the benefit of probiotics is not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCLE INVASIVE BLADDER CANCER (MIBC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sun Yat-sen Memorial Hospital
Guangzhou, Guangdong, 510120, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple blood draw could spot bladder Cancer's return
- Bladder preservation: a viable alternative to radical surgery?
- New drug duo aims to wipe out bladder tumors before surgery
- New bladder cancer combo shows promise in Pre-Surgery trial
- Promising combo aims to shrink bladder tumors before surgery
- Which scan is better for bladder cancer staging? new study aims to find out